-

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Ryvyl Inc. (RVYL) f/k/a Greenbox POS

SAN DIEGO--(BUSINESS WIRE)--The Class: Robbins LLP informs investors that a shareholder filed a class action on behalf of persons or entities who purchased or acquired Rvyl Inc. (NASDAQ: RVYL) f/k/a Greenbox POS: (1) pursuant to the registration statement and prospectus issued in connection with the Company's January 29, 2021 initial public offering ("IPO"); or (ii) between January 29, 2021 and January 20, 2023, for violations of the Securities Act of 1933. Ryvyl is a crypto company focused on developing, marketing and selling blockchain-based payment solutions.

What Now: Similarly situated shareholders may be eligible to participate in the class action against Ryvyl. Shareholders who want to act as lead plaintiff for the class must file their papers by April 3, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

What is this Case About: Ryvyl Inc. (RVYL) Made False and Misleading Statements in Connection with its IPO Regarding its Internal Controls Issues

According to the complaint, the registration statement filed in connection with the IPO was materially false and misleading because it failed to disclose that: (1) the Company would restate certain financials; (2) the Company's internal controls were inadequate; and (3) the Company downplayed and obfuscated its internal control issues.

On January 20, 2023, Ryvyl filed an 8-K with the SEC announcing that its previously issued financial statements as of December 31, 2021, for the year ended December 31, 2021, as of and for the interim periods with the year ended December 31, 2021 and as of and for the interim periods ended September 30, June 30 and March 30, 2021, should no longer be relied upon and had to be restated. The Company further stated that "[i]t is expected that the restatement of the financial statements for the annual and interim periods referred to above will result in decreases to total revenue, increased net losses, decreases to total assets, and decreased total stockholders' equity." On this news, Ryvyl's stock price fell 14.63%, to close at $0.77 per share on January 23, 2023.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Ryvyl Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:RVYL

Release Summary
Ryvyl Inc. (RVYL) Made False and Misleading Statements in Connection with its IPO Regarding its Internal Controls Issues
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the POMDoctor Ltd. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POMDoctor, Ltd. (NASDAQ: POM) securities between October 9, 2025 and December 11, 2025. POMDoctor claims to be "a leading online medical services platform for chronic diseases in China." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Alleg...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Inovio Pharmaceuticals, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all persons that purchased or otherwise acquired Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023 and December 26, 2025. Inovio is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papillomavirus (“HPV”). For more information, submit a...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Masonite International Corporation (k/n/a Owens Corning's Doors) Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all sellers of Masonite International Corporation (NYSE: DOOR) (k/n/a Owens Corning's Doors) common stock between June 5, 2023 and February 8, 2024. Masonite is a leading global designer, manufacturer, marketer, and distributor of interior and exterior doors and door solutions for the residential and non-residential building construction markets’ new construction and repair, renovation and re...
Back to Newsroom